Paper41003140
Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection.
Alkhalifa AE and 4 others. J Pers Med, 2025. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection. Papers, record 41003140. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003140
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anti-Amyloid Monoclonal Antibodies for Alzheimer's Disease: Evidence, ARIA Risk, and Precision Patient Selection.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References123
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27025652 | The amyloid hypothesis of Alzheimer's disease at 25 years. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/27025652 | PubMed |
| 2 | 38692883 | [Mechanism of action and clinical trial results of Lecanemab (Leqembi® 200 mg, 500 mg for Intravenous Infusion), a novel treatment for Alzheimer's disease]. | Nihon Yakurigaku Zasshi | 2024 | https://conductscience.org/library/papers/38692883 | PubMed |
| 3 | 38779110 | Lecanemab: A Second in Class Therapy for the Management of Early Alzheimer's Disease. | Innov Pharm | 2024 | https://conductscience.org/library/papers/38779110 | PubMed |
| 4 | 27048170 | Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody. | Alzheimers Res Ther | 2016 | https://conductscience.org/library/papers/27048170 | PubMed |
| 5 | 35379992 | New insights into the genetic etiology of Alzheimer's disease and related dementias. | Nat Genet | 2022 | https://conductscience.org/library/papers/35379992 | PubMed |
| 6 | 37183523 | The amyloid cascade hypothesis: an updated critical review. | Brain | 2023 | https://conductscience.org/library/papers/37183523 | PubMed |
| 7 | 29653606 | NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29653606 | PubMed |
| 8 | 14755729 | Clinical manifestations of cerebral amyloid angiopathy-related inflammation. | Ann Neurol | 2004 | https://conductscience.org/library/papers/14755729 | PubMed |
| 9 | 28229126 | Assessing quality of life in Alzheimer's disease: Implications for clinical trials. | Alzheimers Dement (Amst) | 2017 | https://conductscience.org/library/papers/28229126 | PubMed |
| 10 | 35953274 | Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical Practice. | AJNR Am J Neuroradiol | 2022 | https://conductscience.org/library/papers/35953274 | PubMed |
| 11 | 19679070 | The role of apolipoprotein E in Alzheimer's disease. | Neuron | 2009 | https://conductscience.org/library/papers/19679070 | PubMed |
| 12 | 32698317 | Monoclonal Antibodies in Cancer Therapy. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/32698317 | PubMed |
| 13 | 1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. | Nature | 1975 | https://conductscience.org/library/papers/1172191 | PubMed |
| 14 | 37955845 | Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease. | BioDrugs | 2024 | https://conductscience.org/library/papers/37955845 | PubMed |
| 15 | 36835161 | Alzheimer's Disease: An Updated Overview of Its Genetics. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36835161 | PubMed |
| 16 | 11528419 | The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. | Nat Neurosci | 2001 | https://conductscience.org/library/papers/11528419 | PubMed |
| 17 | 40327104 | FDA vs. EMA: evaluating donanemab and the global debate on accelerated approvals. | J Neurol | 2025 | https://conductscience.org/library/papers/40327104 | PubMed |
| 18 | 40155270 | Donanemab: Appropriate use recommendations. | J Prev Alzheimers Dis | 2025 | https://conductscience.org/library/papers/40155270 | PubMed |
| 19 | 29686315 | Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β. | Sci Rep | 2018 | https://conductscience.org/library/papers/29686315 | PubMed |
| 20 | 34930757 | Aducanumab: European agency rejects Alzheimer's drug over efficacy and safety concerns. | BMJ | 2021 | https://conductscience.org/library/papers/34930757 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923488 | Protein glycosylation and glycation in Alzheimer's disease: mechanisms, crosstalk, and therapeutic perspectives. | Front Neurosci | 2026 | https://conductscience.org/library/papers/42923488 | PubMed |
| 42909551 | Metabolic Dyshomeostasis, neuroinflammation, and glymphatic clearance deficits as convergent drivers of Alzheimer's disease: an exposome-based conceptual framework for prevention. | Metab Brain Dis | 2026 | https://conductscience.org/library/papers/42909551 | PubMed |
| 42890501 | Effects of West Nile Virus on behavioral and cognitive performance, circadian body temperatures, cortical Aβ and p-tau pathology, and immune measures in human apoE and human amyloid precursor protein NL-G-F/human apoE mice. | Front Immunol | 2026 | https://conductscience.org/library/papers/42890501 | PubMed |
| 42889352 | CD8+ t cell-mediated regulation of synaptic integrity in Alzheimer's disease. | Front Immunol | 2026 | https://conductscience.org/library/papers/42889352 | PubMed |
| 42884722 | Multidimensional Neuroprotective Effects of Combined Ubisol-Q10 and Ashwagandha (Withania somnifera) in Male and Female 5XFAD Mice. | Nutrients | 2026 | https://conductscience.org/library/papers/42884722 | PubMed |
| 42873408 | "Morphological, Functional, and Molecular Progression of Blood-Brain Barrier Dysfunction in Alzheimer's Disease". | J Mol Neurosci | 2026 | https://conductscience.org/library/papers/42873408 | PubMed |
| 42850455 | Organizing healthcare delivery in the era of disease-modifying therapies for Alzheimer's Disease: an Italian RAND/UCLA consensus. | Neurol Sci | 2026 | https://conductscience.org/library/papers/42850455 | PubMed |
| 42801246 | Alzheimer's Disease: From Molecular Pathogenesis to Disease-Modifying Therapies and Clinical Implementation in Aging Populations. | Clin Interv Aging | 2026 | https://conductscience.org/library/papers/42801246 | PubMed |
| 42796561 | Small-Molecule NANT Therapeutics Targeting the Brain-Immune Axis in Alzheimer's Disease: Mechanisms, Clinical Progress, and Translational Challenges. | Molecules | 2026 | https://conductscience.org/library/papers/42796561 | PubMed |
| 42750195 | Operationalizing Alzheimer's disease trials in the era of targeted therapies. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/42750195 | PubMed |
| 42739787 | Anti-Amyloid Antibodies in the Treatment of Alzheimer's Disease: An Umbrella Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739787 | PubMed |
| 42725220 | Before the bolus: why anti-amyloid therapy must become part of every stroke code. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42725220 | PubMed |
| 42654386 | Beyond Amyloid: Systemic and Brain Frailty as Determinants of Response to Anti-Amyloid Therapy in Alzheimer's Disease-A Conceptual Review. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42654386 | PubMed |
| 42627617 | The neuroimmune network in Alzheimer's and Parkinson's diseases: from mechanistic insights to biomarker-guided immunotherapies and clinical translation. | Inflammopharmacology | 2026 | https://conductscience.org/library/papers/42627617 | PubMed |
| 42588092 | Gut Microbiome Changes in Preclinical Alzheimer's Disease. | Nutrients | 2026 | https://conductscience.org/library/papers/42588092 | PubMed |
| 42573852 | Towards Structural Restoration: Epigenetic Reprogramming and Direct Astrocyte-to-Neuron Lineage Conversion as Next-Generation Regenerative Neurotherapeutics. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42573852 | PubMed |
| 42524328 | Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's disease. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42524328 | PubMed |
| 42512081 | Rodent Models of Alzheimer's Disease: Bridging the Translational Gap Through Systems-Level Integration. | Biomedicines | 2026 | https://conductscience.org/library/papers/42512081 | PubMed |
| 42453713 | Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment. | AIMS Neurosci | 2026 | https://conductscience.org/library/papers/42453713 | PubMed |
| 42440728 | Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E. | Alzheimers Dement (N Y) | 2026 | https://conductscience.org/library/papers/42440728 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCA7 | 10347 | PubTator's text mining | https://conductscience.org/library/genes/10347 | NCBI Gene |
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| GFAP | 2670 | PubTator's text mining | https://conductscience.org/library/genes/2670 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
| PSEN1 | 5663 | PubTator's text mining | https://conductscience.org/library/genes/5663 | NCBI Gene |
| PSEN2 | 5664 | PubTator's text mining | https://conductscience.org/library/genes/5664 | NCBI Gene |
| SORL1 | 6653 | PubTator's text mining | https://conductscience.org/library/genes/6653 | NCBI Gene |
| TREM2 | 54209 | PubTator's text mining | https://conductscience.org/library/genes/54209 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003140
GET https://conductscience.org/api/papers/v1/41003140/references?page=2